142 related articles for article (PubMed ID: 29305107)
1. Five threads: How U-shaped thinking weaves together dogs, men, selenium, and prostate cancer risk.
Waters DJ; Chiang EC
Free Radic Biol Med; 2018 Nov; 127():36-45. PubMed ID: 29305107
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model.
Waters DJ; Shen S; Glickman LT; Cooley DM; Bostwick DG; Qian J; Combs GF; Morris JS
Carcinogenesis; 2005 Jul; 26(7):1256-62. PubMed ID: 15817614
[TBL] [Abstract][Full Text] [Related]
3. Defining the Optimal Selenium Dose for Prostate Cancer Risk Reduction: Insights from the U-Shaped Relationship between Selenium Status, DNA Damage, and Apoptosis.
Chiang EC; Shen S; Kengeri SS; Xu H; Combs GF; Morris JS; Bostwick DG; Waters DJ
Dose Response; 2009 Dec; 8(3):285-300. PubMed ID: 20877485
[TBL] [Abstract][Full Text] [Related]
4. Prostatic response to supranutritional selenium supplementation: comparison of the target tissue potency of selenomethionine vs. selenium-yeast on markers of prostatic homeostasis.
Waters DJ; Shen S; Kengeri SS; Chiang EC; Combs GF; Morris JS; Bostwick DG
Nutrients; 2012 Nov; 4(11):1650-63. PubMed ID: 23201838
[TBL] [Abstract][Full Text] [Related]
5. Homeostatic housecleaning effect of selenium: evidence that noncytotoxic oxidant-induced damage sensitizes prostate cancer cells to organic selenium-triggered apoptosis.
Chiang EC; Bostwick DG; Waters DJ
Biofactors; 2013; 39(5):575-88. PubMed ID: 23625367
[TBL] [Abstract][Full Text] [Related]
6. Effects of dietary selenium supplementation on DNA damage and apoptosis in canine prostate.
Waters DJ; Shen S; Cooley DM; Bostwick DG; Qian J; Combs GF; Glickman LT; Oteham C; Schlittler D; Morris JS
J Natl Cancer Inst; 2003 Feb; 95(3):237-41. PubMed ID: 12569146
[TBL] [Abstract][Full Text] [Related]
7. Selenium and vitamin E supplements for prostate cancer: evidence or embellishment?
Moyad MA
Urology; 2002 Apr; 59(4 Suppl 1):9-19. PubMed ID: 11937432
[TBL] [Abstract][Full Text] [Related]
8. [Selenium supplementation trials for cancer prevention and the subsequent risk of type 2 diabetes mellitus: selenium and vitamin E cancer prevention trial and after].
Koyama H; Mutakin ; Abdulah R; Yamazaki C; Kameo S
Nihon Eiseigaku Zasshi; 2013; 68(1):1-10. PubMed ID: 23358371
[TBL] [Abstract][Full Text] [Related]
9. A randomized, controlled chemoprevention trial of selenium in familial prostate cancer: Rationale, recruitment, and design issues.
Costello AJ
Urology; 2001 Apr; 57(4 Suppl 1):182-4. PubMed ID: 11295622
[TBL] [Abstract][Full Text] [Related]
10. Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer.
Helzlsouer KJ; Huang HY; Alberg AJ; Hoffman S; Burke A; Norkus EP; Morris JS; Comstock GW
J Natl Cancer Inst; 2000 Dec; 92(24):2018-23. PubMed ID: 11121464
[TBL] [Abstract][Full Text] [Related]
11. Selenium supplementation and prostate cancer mortality.
Kenfield SA; Van Blarigan EL; DuPre N; Stampfer MJ; L Giovannucci E; Chan JM
J Natl Cancer Inst; 2015 Jan; 107(1):360. PubMed ID: 25505227
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial.
Meyer F; Galan P; Douville P; Bairati I; Kegle P; Bertrais S; Estaquio C; Hercberg S
Int J Cancer; 2005 Aug; 116(2):182-6. PubMed ID: 15800922
[TBL] [Abstract][Full Text] [Related]
13. A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
Gontero P; Marra G; Soria F; Oderda M; Zitella A; Baratta F; Chiorino G; Gregnanin I; Daniele L; Cattel L; Frea B; Brusa P
Prostate; 2015 Aug; 75(11):1177-86. PubMed ID: 25893930
[TBL] [Abstract][Full Text] [Related]
14. Randomized, controlled chemoprevention trials in populations at very high risk for prostate cancer: Elevated prostate-specific antigen and high-grade prostatic intraepithelial neoplasia.
Clark LC; Marshall JR
Urology; 2001 Apr; 57(4 Suppl 1):185-7. PubMed ID: 11295623
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D in blood and risk of prostate cancer: lessons from the Selenium and Vitamin E Cancer Prevention Trial and the Prostate Cancer Prevention Trial.
Schwartz GG
Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1447-9. PubMed ID: 25085835
[TBL] [Abstract][Full Text] [Related]
16. Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study.
Sabichi AL; Lee JJ; Taylor RJ; Thompson IM; Miles BJ; Tangen CM; Minasian LM; Pisters LL; Caton JR; Basler JW; Lerner SP; Menter DG; Marshall JR; Crawford ED; Lippman SM
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2178-84. PubMed ID: 16609032
[TBL] [Abstract][Full Text] [Related]
17. Selenium- or Vitamin E-Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECT.
Chan JM; Darke AK; Penney KL; Tangen CM; Goodman PJ; Lee GM; Sun T; Peisch S; Tinianow AM; Rae JM; Klein EA; Thompson IM; Kantoff PW; Mucci LA
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1050-1058. PubMed ID: 27197287
[TBL] [Abstract][Full Text] [Related]
18. Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial.
Duffield-Lillico AJ; Dalkin BL; Reid ME; Turnbull BW; Slate EH; Jacobs ET; Marshall JR; Clark LC;
BJU Int; 2003 May; 91(7):608-12. PubMed ID: 12699469
[TBL] [Abstract][Full Text] [Related]
19. Making sense of sex and supplements: differences in the anticarcinogenic effects of selenium in men and women.
Waters DJ; Chiang EC; Cooley DM; Morris JS
Mutat Res; 2004 Jul; 551(1-2):91-107. PubMed ID: 15225584
[TBL] [Abstract][Full Text] [Related]
20. Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trial.
Goodman PJ; Tangen CM; Darke AK; Arnold KB; Hartline J; Yee M; Anderson K; Caban-Holt A; Christen WG; Cassano PA; Lance P; Klein EA; Crowley JJ; Minasian LM; Meyskens FL
Trials; 2016 Aug; 17():400. PubMed ID: 27519183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
